Good morning :)
Switch to
Place Order

Lincoln Pharmaceuticals Ltd

LINCOLN
Health CarePharmaceuticals
SmallcapWith a market cap of ₹580 cr, stock is ranked 1,243
Low RiskStock is 1.91x as volatile as Nifty
290.600.00% (+0.00)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹580 cr, stock is ranked 1,243
Low RiskStock is 1.91x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
8.361.340.52%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.474.330.91%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Lincoln Pharmaceuticals Limited (LPL) is engaged in the business of manufacturing, marketing and distribution of pharmaceutical products.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+371.78+397.53+429.85+482.12+48.71+51.42+62.25+69.36
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 2.00%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Annual General Meeting 
Announced OnOct 1, 2022

Lincoln Pharmaceuticals Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 30-Sep-2022 | Download

Lincoln Pharmaceuticals Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 30-Sep-2022 | Download

Annual General Meeting 
Announced OnSep 30, 2022

Lincoln Pharmaceuticals Limited has informed the Exchange about Proceedings of 28th Annual General Meeting held on 30-Sep-2022 | Download

Lincoln Pharmaceuticals Limited has informed the Exchange about Proceedings of 28th Annual General Meeting held on 30-Sep-2022 | Download

Cash Dividend 
Ex. DateSep 15, 2022

Final • Div/Share: ₹ 1.5

See all events